Search

Meningococcal polysaccharide vaccine group A

*N. meningitidis* is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. … It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.

beta-Alanine

beta-Alanine is an amino acid formed in vivo by the degradation of [dihydrouracil] and [carnosine].

DFV890

DFV890 is under investigation in multiple clinical trials for its efficacy, safety, and tolerability across various conditions: NCT06031844 (coronary heart disease with elevated hsCRP), NCT04886258 (symptomatic

Chromic citrate

AICA ribonucleotide

5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) is an intermediate in the generation of inosine monophosphate and analog of adenosine monophosphate (AMP) that is capable of stimulating AMP-dependent … The drug was first used in the 1980s as a method to preserve blood flow to the heart during surgery and is currently of interest as a potential treatment for diabetes by increasing the metabolic activity

Azosemide

Azosemide is a loop diuretic used to treat hypertension, edema, and ascites.

Mesmulogene ancovacivec

with MVA-MUC1-IL2 vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) responses against tumor cells expressing MUC1, a tumor associated antigen, resulting in

Inolimomab

Inolimomab is under investigation as an agent to treat steroid-resistant graft vs host disease.

Cefacetrile

A derivative of 7-aminocephalosporanic acid.

Cefotetan

A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positi...